foxo4-dri clinical trial nct FOX04-DRI (10mg) – Nordsci FOXO4-DRI induces keloid senescent fibroblast
Description
Chemical Properties Purity (each peptide): 99% (HPLC-verified) Form: lyophilized powder Components: BPC-157, GHK-Cu, TB-500 Molecule classes: peptide fragments & copper-peptide complex Solubility: water-soluble after reconstitution Color: characteristic due to copper content (GHK-Cu) Research Relevance GLOW is used to analyse peptide-mediated mechanisms and multi-molecule interactions in preclinical systems
10.1016/j.tim.2017.09.005 153 KasianowiczJ.BenzR.McLaughlinS
Jpn J Pharmacol 2002
That said, this drug combination isnt recommended for men with normal testosterone levels
